Solara Active Pharma Sciences Limited Asset Resilience Ratio

Latest as of September 2025: 0.74%

Solara Active Pharma Sciences Limited asset resilience ratio. Solara Active Pharma Sciences Limited (SOLARA) has an Asset Resilience Ratio of 0.74% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Solara Active Pharma Sciences Limited defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Liquid Assets

Rs169.30 Million

≈ $1.83 Million USD Cash + Short-term Investments

Total Assets

Rs22.93 Billion

≈ $248.03 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Solara Active Pharma Sciences Limited (2018–2025)

Asset resilience ratio of Solara Active Pharma Sciences Limited from 2018 to 2025. This chart shows how Solara Active Pharma Sciences Limited's Asset Resilience Ratio has changed over time. Read Solara Active Pharma Sciences Limited (SOLARA) financial obligations for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Solara Active Pharma Sciences Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see how large is Solara Active Pharma Sciences Limited's balance sheet.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs37.10 Million	0.16%
Short-term Investments	Rs132.20 Million	0.58%
Total Liquid Assets	Rs169.30 Million	0.74%

Asset Resilience Insights

Limited Liquidity: Solara Active Pharma Sciences Limited maintains only 0.74% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Solara Active Pharma Sciences Limited Industry Peers by Asset Resilience Ratio

Compare Solara Active Pharma Sciences Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Jiangsu Nhwa Pharmaceutical Co Ltd SHE:002262	Drug Manufacturers - Specialty & Generic	26.45%
Tibet Rhodiola Pharmaceutical Holding Co SHG:600211	Drug Manufacturers - Specialty & Generic	11.84%
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	Drug Manufacturers - Specialty & Generic	26.36%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%
Bide Pharmatech Co. Ltd. A SHG:688073	Drug Manufacturers - Specialty & Generic	9.46%
Jianmin Pharmaceutical Group Co Ltd SHG:600976	Drug Manufacturers - Specialty & Generic	20.61%
Qianjiang Yongan Pharmaceutical Co Ltd SHE:002365	Drug Manufacturers - Specialty & Generic	30.38%
Shenzhen Neptunus Bioengineering Co Ltd SHE:000078	Drug Manufacturers - Specialty & Generic	0.42%

Solara Active Pharma Sciences Limited Asset Resilience Ratio by Year (2018–2025)

Solara Active Pharma Sciences Limited asset resilience ratio by year from 2018 to 2025. The table below shows the annual Asset Resilience Ratio data for Solara Active Pharma Sciences Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-03-31	0.74%	Rs164.70 Million ≈ $1.78 Million	Rs22.32 Billion ≈ $241.37 Million	+0.42pp
2024-03-31	0.32%	Rs75.80 Million ≈ $819.75K	Rs23.51 Billion ≈ $254.25 Million	-0.44pp
2023-03-31	0.76%	Rs221.20 Million ≈ $2.39 Million	Rs28.99 Billion ≈ $313.52 Million	-1.03pp
2022-03-31	1.79%	Rs528.70 Million ≈ $5.72 Million	Rs29.53 Billion ≈ $319.30 Million	-6.74pp
2021-03-31	8.54%	Rs2.23 Billion ≈ $24.13 Million	Rs26.14 Billion ≈ $282.65 Million	+5.28pp
2020-03-31	3.25%	Rs700.50 Million ≈ $7.58 Million	Rs21.54 Billion ≈ $232.89 Million	+3.12pp
2019-03-31	0.13%	Rs25.98 Million ≈ $280.96K	Rs19.60 Billion ≈ $211.97 Million	+0.34pp
2018-03-31	-0.21%	Rs-38.17 Million ≈ $-412.79K	Rs18.22 Billion ≈ $196.99 Million	--

pp = percentage points

About Solara Active Pharma Sciences Limited

NSE:SOLARA India Drug Manufacturers - Specialty & Generic

Market Cap

$246.34 Million

Rs22.78 Billion INR

Market Cap Rank

#15486 Global

#781 in India

Share Price

Rs629.75

Change (1 day)

-1.32%

52-Week Range

Rs425.55 - Rs753.25

All Time High

Rs1807.78